According to New Scientist, hormone replacement therapy (HRT) taken during perimenopause may reduce the risk of cardiovascular disease, including heart attacks and stroke. The report suggests that the timing of when HRT is started could be decisive, with perimenopause emerging as a potentially important period for intervention.
While the findings point to a protective effect, the source emphasizes that the benefit depends on starting treatment at the right time. Further research is needed to clarify how this timing influences long-term cardiovascular outcomes in women transitioning through perimenopause.